Industries

Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Latest Trends in M&A and Alternative Deal Structures in the Biopharma Market

CPE 1.0

Webcast

Webcast overview

Join professionals from the KPMG Life Sciences Practice for a webcast that will provide valuable insights into the future state of life sciences investments, with a specific focus on emerging biopharma organizations, as well as the tax implications surrounding these deals.

During this event, we will take a deeper dive into the 2024 life sciences investment outlook, exploring the opportunities and challenges that lie ahead for emerging biopharma companies. Our speakers will share their expertise and provide actionable strategies to navigate the evolving landscape successfully.

Explore more

Webcast Replay Webcast Upcoming Listen Now

2024 Healthcare and Life Sciences Investment Outlook

We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.

Healthcare and life sciences M&A: Poised for a rebound?
Webcast Replay Webcast Upcoming Listen Now

Healthcare and life sciences M&A: Poised for a rebound?

After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.

KPMG Life Sciences CEO Outlook

Exploring CEO views on the economy, disruptive technology and ESG

Exploring CEO views on the economy, disruptive technology and ESG

Facing pricing pressures, patent expirations and rising R&D costs, life sciences CEOs expect slower growth over the next three years. Based on research from KPMG, this article finds that sector CEOs are exploring opportunities to boost their trajectory using new technologies such as generative AI – supported by a stronger digital foundation. At the same time, appetite for M&A remains strong with many CEOs saying they will make strategic deals when markets stabilize.

Read more

Explore other services

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.

Headline